Sulfasalazine Clinical Trials

6 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: Azulfidine

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 2Phase 1/2: 2

Top Sponsors

University of Zurich1
University of Nebraska1
Tanta University1
NYU Langone Health1
Eccogene1

Indications

Cancer3
Arthritis2
Rheumatic Disease1
Liver Disease1
Non-alcoholic Fatty Liver Disease NAFLD1

Other4 trials

Glutamate Inhibitors in Glioblastoma

Phase 1/2

Study of ECC4703 With Sulfasalazine and Pitavastatin

Phase 1

Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

Phase 1/2

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Phase 3

Omaha, Nebraska1 trial

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

University of Nebraska Medical Center

Phase 3

New York, New York1 trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NYU Langone Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.